MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$5,505K
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
--5,080 5,336
General and administrative
--967 1,000
Total operating expenses
--6,047 6,336
Loss from operations
-6,274 -37,110* -6,047 -6,336
Interest income
914 1,244* 1,427 1,530
Interest expense
0 -88* 0 0
Other expense
1,036 1,589* -85 -3
Foreign exchange (loss) gain
-1,132 513* -1,201 3,081
Total other income
818 3,257* 141 4,608
Income before income taxes
-5,456 -33,854* -5,906 -1,728
Income tax expense
49 40* 102 28
Net loss
-5,505 -33,894 -6,008 -1,756
Basic EPS
-0.18 -1.112 -0.2 -0.06
Diluted EPS
--1.112 --
Basic Average Shares
30,487,731 30,487,731 30,487,731 30,487,731
Diluted Average Shares
-30,487,731 --
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$5,505K Other expense$1,036K Interest income$914K Income before incometaxes-$5,456K Income tax expense$49K Total other income$818K Foreign exchange (loss)gain-$1,132K Loss from operations-$6,274K

XBiotech Inc. (XBIT)

XBiotech Inc. (XBIT)